Related Experiment Video
Updated: Jun 25, 2026
05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 27, 2013
Pre-hospital thrombolysis, is it useful?
A D Castaigne1, C Hervé, A M Duval-Moulin
1Cardiology Department, Hôpital Henri Mondor, Creteil, France.
European Heart Journal
|August 1, 1990
Summary
Pre-hospital thrombolysis with APSAC is feasible and safe, potentially shortening treatment delays for acute myocardial infarction. Further large-scale studies are ongoing to determine its overall usefulness compared to in-hospital administration.
Area of Science:
- Cardiology
- Emergency Medicine
- Pharmacology
Background:
- Thrombolytic treatment efficacy for acute myocardial infarction (AMI) is time-dependent.
- Shortening the delay between pain onset and treatment is crucial for improving outcomes.
- Pre-hospital administration of thrombolytics could reduce treatment delays.
Purpose of the Study:
- To assess the feasibility, safety, and potential usefulness of pre-hospital thrombolysis for AMI.
- To evaluate the administration of Anistreplase (APSAC) in a pre-hospital setting.
Main Methods:
- Demonstration of feasibility and safety of pre-hospital thrombolysis with APSAC.
- Comparison of findings with other studies using different thrombolytic agents.
- Ongoing large-scale studies (Seattle, European Myocardial Infarction Project) evaluating pre-hospital vs. in-hospital thrombolysis endpoints (left ventricular ejection fraction, total mortality).
Main Results:
- Pre-hospital thrombolysis with APSAC has been demonstrated to be feasible, easy to administer, and safe.
- Current findings align with other research on pre-hospital thrombolysis using various drugs.
- The ultimate usefulness of pre-hospital thrombolysis requires further assessment through large-scale trials.
Conclusions:
- Pre-hospital thrombolysis with APSAC is a safe and feasible option for reducing treatment delays in AMI.
- Further research is needed to definitively establish the clinical utility and benefits of pre-hospital thrombolysis compared to in-hospital administration.
- Results from ongoing large-scale studies are anticipated to provide definitive answers on the usefulness of this approach.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:27Pulmonary Embolism III: Nursing Management
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...